H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 34,754 169 World Ranking 15376 National Ranking 7976

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Gene

Michael Spedding mainly focuses on Pharmacology, Receptor, Neuroscience, Drug discovery and Clinical pharmacology. Michael Spedding has included themes like Signal transduction, Ion channel and Small molecule in his Pharmacology study. As part of one scientific family, Michael Spedding deals mainly with the area of Receptor, narrowing it down to issues related to the Nuclear receptor, and often SUPERFAMILY and Phylogenetics.

The various areas that he examines in his Neuroscience study include Autophagy and Cell biology. The concepts of his Drug discovery study are interwoven with issues in Sequence database, UniProt and Functional selectivity. His Clinical pharmacology research integrates issues from Immunopharmacology and Human proteins.

His most cited work include:

  • International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels (7252 citations)
  • The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY (1273 citations)
  • A unified nomenclature system for the nuclear receptor superfamily (1009 citations)

What are the main themes of his work throughout his whole career to date?

Michael Spedding spends much of his time researching Pharmacology, Internal medicine, Endocrinology, Neuroscience and Receptor. His Pharmacology study also includes

  • Antagonist together with Stereochemistry,
  • Drug discovery and related Clinical pharmacology. His work in Ligand and Serotonin are all subfields of Internal medicine research.

His Endocrinology study integrates concerns from other disciplines, such as Verapamil, Calcium, Neuroprotection, Binding site and Idazoxan. His research in Neuroscience intersects with topics in AMPA receptor and Long-term potentiation. His study on Receptor is covered under Biochemistry.

He most often published in these fields:

  • Pharmacology (26.87%)
  • Internal medicine (20.00%)
  • Endocrinology (19.06%)

What were the highlights of his more recent work (between 2011-2021)?

  • Pharmacology (26.87%)
  • Neuroscience (14.69%)
  • Drug discovery (5.31%)

In recent papers he was focusing on the following fields of study:

Michael Spedding mainly investigates Pharmacology, Neuroscience, Drug discovery, Prefrontal cortex and Clinical pharmacology. Michael Spedding has researched Pharmacology in several fields, including Receptor, Ion channel, Nuclear receptor and Small molecule. His Neuroscience research focuses on Schizophrenia and how it relates to Neuroplasticity, Autism and Psychosis.

His Drug discovery research is multidisciplinary, incorporating perspectives in Immunopharmacology and Drug. His work carried out in the field of Prefrontal cortex brings together such families of science as Long-term potentiation, Endocrinology, Hippocampus and Electrophysiology. His studies deal with areas such as Drug classification, PubChem and UniProt as well as Clinical pharmacology.

Between 2011 and 2021, his most popular works were:

  • The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY (1273 citations)
  • The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands (961 citations)
  • The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands (778 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Gene

His main research concerns Pharmacology, Clinical pharmacology, Neuroscience, Catalytic receptors and Receptor. His Pharmacology research incorporates themes from Membrane transport protein, Enzyme, Small molecule, Ion channel and Nuclear receptor. His Clinical pharmacology study combines topics from a wide range of disciplines, such as Immunopharmacology and Drug discovery.

His Drug discovery research includes themes of PubChem, UniProt and Human proteins. His Neuroscience research integrates issues from Psychotropic Agent and Schizophrenia. His G protein-coupled receptor, 5-HT1 receptor and Ligand-gated ion channel study in the realm of Receptor connects with subjects such as CMKLR1.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

W. A. Catterall;K. G. Chandy;D. E. Clapham;G. A. Gutman.
Pharmacological Reviews (2003)

12815 Citations

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors

Stephen P.H. Alexander;Helen E. Benson;Elena Faccenda;Adam J. Pawson.
British Journal of Pharmacology (2013)

1464 Citations

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Simon D. Harding;Joanna L. Sharman;Elena Faccenda;Christopher Southan.
Nucleic Acids Research (2018)

1455 Citations

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Jonathan D. Urban;William P. Clarke;Mark Von Zastrow;David E. Nichols.
Journal of Pharmacology and Experimental Therapeutics (2007)

1149 Citations

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Christopher Southan;Joanna L. Sharman;Helen E. Benson;Elena Faccenda.
Nucleic Acids Research (2016)

1062 Citations

A unified nomenclature system for the nuclear receptor superfamily

J. Auwerx;E. Baulieu;M. Beato;M. Becker-Andre.
Cell (1999)

1053 Citations

Anti-inflammatory actions of steroids: molecular mechanisms

Peter J. Barnes;Ian Adcock;Michael Spedding;Paul M. Vanhoutte.
Trends in Pharmacological Sciences (1993)

1008 Citations

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Mark J. Millan;Yves Agid;Martin Brüne;Edward T. Bullmore.
Nature Reviews Drug Discovery (2012)

911 Citations

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Adam J. Pawson;Joanna L. Sharman;Helen E. Benson;Elena Faccenda.
Nucleic Acids Research (2014)

843 Citations

Overview of Nomenclature of Nuclear Receptors

Pierre Germain;Bart Staels;Catherine Dacquet;Michael Spedding.
Pharmacological Reviews (2006)

754 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael Spedding

Mark J. Millan

Mark J. Millan

University of Glasgow

Publications: 95

Arthur Christopoulos

Arthur Christopoulos

Monash University

Publications: 89

Bryan L. Roth

Bryan L. Roth

University of North Carolina at Chapel Hill

Publications: 65

Patrick M. Sexton

Patrick M. Sexton

Monash University

Publications: 65

Geoffrey Burnstock

Geoffrey Burnstock

University of Melbourne

Publications: 58

Walter Wahli

Walter Wahli

Nanyang Technological University

Publications: 57

Morley D. Hollenberg

Morley D. Hollenberg

University of Calgary

Publications: 52

Graeme Milligan

Graeme Milligan

University of Glasgow

Publications: 50

Pierre Gressens

Pierre Gressens

Université Paris Cité

Publications: 48

Roland Seifert

Roland Seifert

Hannover Medical School

Publications: 44

Vincent Laudet

Vincent Laudet

Okinawa Institute of Science and Technology

Publications: 43

Paolo Fusar-Poli

Paolo Fusar-Poli

South London and Maudsley NHS Foundation Trust

Publications: 42

Kenneth A. Jacobson

Kenneth A. Jacobson

National Institutes of Health

Publications: 42

Jean-Philippe Pin

Jean-Philippe Pin

University of Montpellier

Publications: 41

Rafael Franco

Rafael Franco

University of Barcelona

Publications: 41

György Haskó

György Haskó

Columbia University

Publications: 38

Something went wrong. Please try again later.